nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—Acute respiratory distress syndrome—Pamidronate—Paget's disease of bone	0.0191	0.0487	CcSEcCtD
Crizotinib—Lymphopenia—Alendronate—Paget's disease of bone	0.0128	0.0325	CcSEcCtD
Crizotinib—Transaminases increased—Alendronate—Paget's disease of bone	0.0107	0.0274	CcSEcCtD
Crizotinib—Lymphopenia—Pamidronate—Paget's disease of bone	0.00973	0.0248	CcSEcCtD
Crizotinib—Hypophosphataemia—Pamidronate—Paget's disease of bone	0.00856	0.0219	CcSEcCtD
Crizotinib—Hypophosphataemia—Zoledronate—Paget's disease of bone	0.00782	0.02	CcSEcCtD
Crizotinib—Neuralgia—Risedronate—Paget's disease of bone	0.00754	0.0192	CcSEcCtD
Crizotinib—Interstitial lung disease—Pamidronate—Paget's disease of bone	0.00703	0.0179	CcSEcCtD
Crizotinib—Interstitial lung disease—Zoledronate—Paget's disease of bone	0.00642	0.0164	CcSEcCtD
Crizotinib—Dyspepsia—Tiludronate—Paget's disease of bone	0.00502	0.0128	CcSEcCtD
Crizotinib—Neuropathy peripheral—Etidronic acid—Paget's disease of bone	0.0042	0.0107	CcSEcCtD
Crizotinib—Hepatic function abnormal—Pamidronate—Paget's disease of bone	0.00413	0.0105	CcSEcCtD
Crizotinib—Asthenia—Tiludronate—Paget's disease of bone	0.00409	0.0104	CcSEcCtD
Crizotinib—Diarrhoea—Tiludronate—Paget's disease of bone	0.0039	0.00996	CcSEcCtD
Crizotinib—Dizziness—Tiludronate—Paget's disease of bone	0.00377	0.00963	CcSEcCtD
Crizotinib—Nausea—Tiludronate—Paget's disease of bone	0.00339	0.00865	CcSEcCtD
Crizotinib—Muscular weakness—Risedronate—Paget's disease of bone	0.00335	0.00855	CcSEcCtD
Crizotinib—Hypokalaemia—Pamidronate—Paget's disease of bone	0.00329	0.00839	CcSEcCtD
Crizotinib—Oedema peripheral—Alendronate—Paget's disease of bone	0.00323	0.00824	CcSEcCtD
Crizotinib—Anaemia—Etidronic acid—Paget's disease of bone	0.00309	0.0079	CcSEcCtD
Crizotinib—Upper respiratory tract infection—Risedronate—Paget's disease of bone	0.00305	0.00779	CcSEcCtD
Crizotinib—Hypokalaemia—Zoledronate—Paget's disease of bone	0.003	0.00766	CcSEcCtD
Crizotinib—Leukopenia—Etidronic acid—Paget's disease of bone	0.003	0.00765	CcSEcCtD
Crizotinib—Pneumonia—Risedronate—Paget's disease of bone	0.00295	0.00752	CcSEcCtD
Crizotinib—Infestation NOS—Risedronate—Paget's disease of bone	0.00293	0.00747	CcSEcCtD
Crizotinib—Infestation—Risedronate—Paget's disease of bone	0.00293	0.00747	CcSEcCtD
Crizotinib—Neutropenia—Pamidronate—Paget's disease of bone	0.00292	0.00745	CcSEcCtD
Crizotinib—Muscular weakness—Zoledronate—Paget's disease of bone	0.00291	0.00743	CcSEcCtD
Crizotinib—Upper respiratory tract infection—Pamidronate—Paget's disease of bone	0.0029	0.00741	CcSEcCtD
Crizotinib—Pneumonia—Pamidronate—Paget's disease of bone	0.0028	0.00715	CcSEcCtD
Crizotinib—Dysgeusia—Alendronate—Paget's disease of bone	0.00279	0.00713	CcSEcCtD
Crizotinib—Infestation NOS—Pamidronate—Paget's disease of bone	0.00278	0.0071	CcSEcCtD
Crizotinib—Infestation—Pamidronate—Paget's disease of bone	0.00278	0.0071	CcSEcCtD
Crizotinib—Hepatobiliary disease—Risedronate—Paget's disease of bone	0.00277	0.00707	CcSEcCtD
Crizotinib—Infection—Etidronic acid—Paget's disease of bone	0.00271	0.00693	CcSEcCtD
Crizotinib—Neutropenia—Zoledronate—Paget's disease of bone	0.00267	0.00681	CcSEcCtD
Crizotinib—Upper respiratory tract infection—Zoledronate—Paget's disease of bone	0.00265	0.00676	CcSEcCtD
Crizotinib—Anaemia—Alendronate—Paget's disease of bone	0.00264	0.00673	CcSEcCtD
Crizotinib—Urinary tract disorder—Risedronate—Paget's disease of bone	0.0026	0.00663	CcSEcCtD
Crizotinib—Oedema peripheral—Risedronate—Paget's disease of bone	0.00259	0.00661	CcSEcCtD
Crizotinib—Weight decreased—Zoledronate—Paget's disease of bone	0.00258	0.00659	CcSEcCtD
Crizotinib—Urethral disorder—Risedronate—Paget's disease of bone	0.00258	0.00658	CcSEcCtD
Crizotinib—Infestation NOS—Zoledronate—Paget's disease of bone	0.00254	0.00649	CcSEcCtD
Crizotinib—Infestation—Zoledronate—Paget's disease of bone	0.00254	0.00649	CcSEcCtD
Crizotinib—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.00247	0.0063	CcSEcCtD
Crizotinib—Eye disorder—Risedronate—Paget's disease of bone	0.00246	0.00627	CcSEcCtD
Crizotinib—Paraesthesia—Etidronic acid—Paget's disease of bone	0.00245	0.00626	CcSEcCtD
Crizotinib—Urethral disorder—Pamidronate—Paget's disease of bone	0.00245	0.00625	CcSEcCtD
Crizotinib—Cardiac disorder—Risedronate—Paget's disease of bone	0.00244	0.00623	CcSEcCtD
Crizotinib—Dyspepsia—Etidronic acid—Paget's disease of bone	0.0024	0.00614	CcSEcCtD
Crizotinib—Mediastinal disorder—Risedronate—Paget's disease of bone	0.00237	0.00605	CcSEcCtD
Crizotinib—Arrhythmia—Risedronate—Paget's disease of bone	0.00235	0.00599	CcSEcCtD
Crizotinib—Constipation—Etidronic acid—Paget's disease of bone	0.00234	0.00596	CcSEcCtD
Crizotinib—Eye disorder—Pamidronate—Paget's disease of bone	0.00234	0.00596	CcSEcCtD
Crizotinib—Bradycardia—Zoledronate—Paget's disease of bone	0.00232	0.00593	CcSEcCtD
Crizotinib—Cardiac disorder—Pamidronate—Paget's disease of bone	0.00232	0.00592	CcSEcCtD
Crizotinib—Infection—Alendronate—Paget's disease of bone	0.00231	0.0059	CcSEcCtD
Crizotinib—Malnutrition—Risedronate—Paget's disease of bone	0.00229	0.00584	CcSEcCtD
Crizotinib—Hypoaesthesia—Zoledronate—Paget's disease of bone	0.00227	0.0058	CcSEcCtD
Crizotinib—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.00225	0.00575	CcSEcCtD
Crizotinib—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.00225	0.00575	CcSEcCtD
Crizotinib—Oedema peripheral—Zoledronate—Paget's disease of bone	0.00225	0.00574	CcSEcCtD
Crizotinib—Urethral disorder—Zoledronate—Paget's disease of bone	0.00224	0.00571	CcSEcCtD
Crizotinib—Malnutrition—Pamidronate—Paget's disease of bone	0.00218	0.00555	CcSEcCtD
Crizotinib—Eye disorder—Zoledronate—Paget's disease of bone	0.00213	0.00544	CcSEcCtD
Crizotinib—Dysgeusia—Pamidronate—Paget's disease of bone	0.00213	0.00544	CcSEcCtD
Crizotinib—Cardiac disorder—Zoledronate—Paget's disease of bone	0.00212	0.00541	CcSEcCtD
Crizotinib—Anaemia—Risedronate—Paget's disease of bone	0.00212	0.0054	CcSEcCtD
Crizotinib—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.00206	0.00525	CcSEcCtD
Crizotinib—Syncope—Risedronate—Paget's disease of bone	0.00205	0.00524	CcSEcCtD
Crizotinib—Dyspepsia—Alendronate—Paget's disease of bone	0.00205	0.00523	CcSEcCtD
Crizotinib—Arrhythmia—Zoledronate—Paget's disease of bone	0.00204	0.0052	CcSEcCtD
Crizotinib—Loss of consciousness—Risedronate—Paget's disease of bone	0.00201	0.00513	CcSEcCtD
Crizotinib—Anaemia—Pamidronate—Paget's disease of bone	0.00201	0.00513	CcSEcCtD
Crizotinib—Constipation—Alendronate—Paget's disease of bone	0.00199	0.00508	CcSEcCtD
Crizotinib—Malnutrition—Zoledronate—Paget's disease of bone	0.00199	0.00507	CcSEcCtD
Crizotinib—Syncope—Pamidronate—Paget's disease of bone	0.00195	0.00498	CcSEcCtD
Crizotinib—Leukopenia—Pamidronate—Paget's disease of bone	0.00195	0.00497	CcSEcCtD
Crizotinib—Dysgeusia—Zoledronate—Paget's disease of bone	0.00195	0.00497	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00193	0.00494	CcSEcCtD
Crizotinib—Loss of consciousness—Pamidronate—Paget's disease of bone	0.00191	0.00488	CcSEcCtD
Crizotinib—Vision blurred—Zoledronate—Paget's disease of bone	0.00187	0.00478	CcSEcCtD
Crizotinib—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00187	0.00477	CcSEcCtD
Crizotinib—Infection—Risedronate—Paget's disease of bone	0.00186	0.00474	CcSEcCtD
Crizotinib—Body temperature increased—Alendronate—Paget's disease of bone	0.00184	0.0047	CcSEcCtD
Crizotinib—Shock—Risedronate—Paget's disease of bone	0.00184	0.00469	CcSEcCtD
Crizotinib—Anaemia—Zoledronate—Paget's disease of bone	0.00184	0.00469	CcSEcCtD
Crizotinib—Nervous system disorder—Risedronate—Paget's disease of bone	0.00183	0.00467	CcSEcCtD
Crizotinib—Skin disorder—Risedronate—Paget's disease of bone	0.00181	0.00463	CcSEcCtD
Crizotinib—Syncope—Zoledronate—Paget's disease of bone	0.00178	0.00455	CcSEcCtD
Crizotinib—Leukopenia—Zoledronate—Paget's disease of bone	0.00178	0.00454	CcSEcCtD
Crizotinib—Oedema—Pamidronate—Paget's disease of bone	0.00178	0.00453	CcSEcCtD
Crizotinib—Infection—Pamidronate—Paget's disease of bone	0.00176	0.0045	CcSEcCtD
Crizotinib—Shock—Pamidronate—Paget's disease of bone	0.00175	0.00446	CcSEcCtD
Crizotinib—Loss of consciousness—Zoledronate—Paget's disease of bone	0.00175	0.00446	CcSEcCtD
Crizotinib—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00174	0.00444	CcSEcCtD
Crizotinib—Vomiting—Etidronic acid—Paget's disease of bone	0.00174	0.00443	CcSEcCtD
Crizotinib—Rash—Etidronic acid—Paget's disease of bone	0.00172	0.0044	CcSEcCtD
Crizotinib—Dermatitis—Etidronic acid—Paget's disease of bone	0.00172	0.00439	CcSEcCtD
Crizotinib—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.00168	0.00429	CcSEcCtD
Crizotinib—Paraesthesia—Risedronate—Paget's disease of bone	0.00168	0.00428	CcSEcCtD
Crizotinib—Asthenia—Alendronate—Paget's disease of bone	0.00167	0.00426	CcSEcCtD
Crizotinib—Dyspnoea—Risedronate—Paget's disease of bone	0.00167	0.00425	CcSEcCtD
Crizotinib—Dyspepsia—Risedronate—Paget's disease of bone	0.00164	0.0042	CcSEcCtD
Crizotinib—Nausea—Etidronic acid—Paget's disease of bone	0.00162	0.00414	CcSEcCtD
Crizotinib—Oedema—Zoledronate—Paget's disease of bone	0.00162	0.00414	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00161	0.00412	CcSEcCtD
Crizotinib—Infection—Zoledronate—Paget's disease of bone	0.00161	0.00411	CcSEcCtD
Crizotinib—Fatigue—Risedronate—Paget's disease of bone	0.00161	0.00411	CcSEcCtD
Crizotinib—Constipation—Risedronate—Paget's disease of bone	0.0016	0.00408	CcSEcCtD
Crizotinib—Shock—Zoledronate—Paget's disease of bone	0.0016	0.00407	CcSEcCtD
Crizotinib—Paraesthesia—Pamidronate—Paget's disease of bone	0.00159	0.00407	CcSEcCtD
Crizotinib—Diarrhoea—Alendronate—Paget's disease of bone	0.00159	0.00406	CcSEcCtD
Crizotinib—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00159	0.00406	CcSEcCtD
Crizotinib—Dyspnoea—Pamidronate—Paget's disease of bone	0.00158	0.00404	CcSEcCtD
Crizotinib—Skin disorder—Zoledronate—Paget's disease of bone	0.00158	0.00402	CcSEcCtD
Crizotinib—Dyspepsia—Pamidronate—Paget's disease of bone	0.00156	0.00399	CcSEcCtD
Crizotinib—Decreased appetite—Pamidronate—Paget's disease of bone	0.00154	0.00394	CcSEcCtD
Crizotinib—Dizziness—Alendronate—Paget's disease of bone	0.00154	0.00393	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00153	0.00391	CcSEcCtD
Crizotinib—Fatigue—Pamidronate—Paget's disease of bone	0.00153	0.00391	CcSEcCtD
Crizotinib—Constipation—Pamidronate—Paget's disease of bone	0.00152	0.00387	CcSEcCtD
Crizotinib—Vomiting—Alendronate—Paget's disease of bone	0.00148	0.00378	CcSEcCtD
Crizotinib—Body temperature increased—Risedronate—Paget's disease of bone	0.00148	0.00377	CcSEcCtD
Crizotinib—Rash—Alendronate—Paget's disease of bone	0.00147	0.00375	CcSEcCtD
Crizotinib—Dermatitis—Alendronate—Paget's disease of bone	0.00147	0.00374	CcSEcCtD
Crizotinib—Paraesthesia—Zoledronate—Paget's disease of bone	0.00146	0.00372	CcSEcCtD
Crizotinib—Dyspnoea—Zoledronate—Paget's disease of bone	0.00145	0.00369	CcSEcCtD
Crizotinib—Dyspepsia—Zoledronate—Paget's disease of bone	0.00143	0.00364	CcSEcCtD
Crizotinib—Decreased appetite—Zoledronate—Paget's disease of bone	0.00141	0.0036	CcSEcCtD
Crizotinib—Body temperature increased—Pamidronate—Paget's disease of bone	0.0014	0.00358	CcSEcCtD
Crizotinib—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.0014	0.00357	CcSEcCtD
Crizotinib—Fatigue—Zoledronate—Paget's disease of bone	0.0014	0.00357	CcSEcCtD
Crizotinib—Constipation—Zoledronate—Paget's disease of bone	0.00139	0.00354	CcSEcCtD
Crizotinib—Nausea—Alendronate—Paget's disease of bone	0.00138	0.00353	CcSEcCtD
Crizotinib—Asthenia—Risedronate—Paget's disease of bone	0.00134	0.00342	CcSEcCtD
Crizotinib—Body temperature increased—Zoledronate—Paget's disease of bone	0.00128	0.00327	CcSEcCtD
Crizotinib—Diarrhoea—Risedronate—Paget's disease of bone	0.00128	0.00326	CcSEcCtD
Crizotinib—Asthenia—Pamidronate—Paget's disease of bone	0.00127	0.00325	CcSEcCtD
Crizotinib—Dizziness—Risedronate—Paget's disease of bone	0.00124	0.00315	CcSEcCtD
Crizotinib—Diarrhoea—Pamidronate—Paget's disease of bone	0.00121	0.0031	CcSEcCtD
Crizotinib—Vomiting—Risedronate—Paget's disease of bone	0.00119	0.00303	CcSEcCtD
Crizotinib—Rash—Risedronate—Paget's disease of bone	0.00118	0.00301	CcSEcCtD
Crizotinib—Dermatitis—Risedronate—Paget's disease of bone	0.00118	0.003	CcSEcCtD
Crizotinib—Dizziness—Pamidronate—Paget's disease of bone	0.00117	0.003	CcSEcCtD
Crizotinib—Asthenia—Zoledronate—Paget's disease of bone	0.00116	0.00297	CcSEcCtD
Crizotinib—Vomiting—Pamidronate—Paget's disease of bone	0.00113	0.00288	CcSEcCtD
Crizotinib—Rash—Pamidronate—Paget's disease of bone	0.00112	0.00286	CcSEcCtD
Crizotinib—Dermatitis—Pamidronate—Paget's disease of bone	0.00112	0.00285	CcSEcCtD
Crizotinib—Diarrhoea—Zoledronate—Paget's disease of bone	0.00111	0.00283	CcSEcCtD
Crizotinib—Nausea—Risedronate—Paget's disease of bone	0.00111	0.00283	CcSEcCtD
Crizotinib—Dizziness—Zoledronate—Paget's disease of bone	0.00107	0.00274	CcSEcCtD
Crizotinib—Nausea—Pamidronate—Paget's disease of bone	0.00105	0.00269	CcSEcCtD
Crizotinib—Vomiting—Zoledronate—Paget's disease of bone	0.00103	0.00263	CcSEcCtD
Crizotinib—Rash—Zoledronate—Paget's disease of bone	0.00102	0.00261	CcSEcCtD
Crizotinib—Dermatitis—Zoledronate—Paget's disease of bone	0.00102	0.00261	CcSEcCtD
Crizotinib—Nausea—Zoledronate—Paget's disease of bone	0.000963	0.00246	CcSEcCtD
Crizotinib—LCK—Signaling by Interleukins—INPP5D—Paget's disease of bone	0.000623	0.00102	CbGpPWpGaD
Crizotinib—JAK3—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000618	0.00102	CbGpPWpGaD
Crizotinib—RIPK2—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000615	0.00101	CbGpPWpGaD
Crizotinib—PTK2B—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000606	0.000996	CbGpPWpGaD
Crizotinib—AURKA—Cell Cycle—NUP205—Paget's disease of bone	0.000602	0.000989	CbGpPWpGaD
Crizotinib—ABL1—Integrated Breast Cancer Pathway—PML—Paget's disease of bone	0.0006	0.000986	CbGpPWpGaD
Crizotinib—SRC—Cell surface interactions at the vascular wall—INPP5D—Paget's disease of bone	0.000591	0.000972	CbGpPWpGaD
Crizotinib—JAK2—Interferon Signaling—NUP205—Paget's disease of bone	0.000583	0.000959	CbGpPWpGaD
Crizotinib—PLK4—Cell Cycle—NUP205—Paget's disease of bone	0.000577	0.000948	CbGpPWpGaD
Crizotinib—TEK—Hemostasis—INPP5D—Paget's disease of bone	0.00057	0.000937	CbGpPWpGaD
Crizotinib—LCK—Signaling by Interleukins—SQSTM1—Paget's disease of bone	0.000559	0.000918	CbGpPWpGaD
Crizotinib—YES1—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000558	0.000917	CbGpPWpGaD
Crizotinib—RIPK2—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000551	0.000906	CbGpPWpGaD
Crizotinib—ABL1—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.000547	0.000899	CbGpPWpGaD
Crizotinib—PTK2B—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000543	0.000893	CbGpPWpGaD
Crizotinib—RIPK2—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000542	0.000891	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—VCP—Paget's disease of bone	0.000538	0.000885	CbGpPWpGaD
Crizotinib—IRAK1—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000529	0.00087	CbGpPWpGaD
Crizotinib—TXK—Immune System—NUP205—Paget's disease of bone	0.000519	0.000853	CbGpPWpGaD
Crizotinib—JAK2—Interferon Signaling—PML—Paget's disease of bone	0.000515	0.000847	CbGpPWpGaD
Crizotinib—JAK2—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.000514	0.000846	CbGpPWpGaD
Crizotinib—TYK2—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000514	0.000845	CbGpPWpGaD
Crizotinib—NTRK1—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000511	0.00084	CbGpPWpGaD
Crizotinib—JAK2—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.000507	0.000833	CbGpPWpGaD
Crizotinib—SRC—Senescence and Autophagy in Cancer—SQSTM1—Paget's disease of bone	0.000506	0.000832	CbGpPWpGaD
Crizotinib—ABL1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000497	0.000817	CbGpPWpGaD
Crizotinib—CDK7—Cell Cycle, Mitotic—NUP205—Paget's disease of bone	0.000497	0.000817	CbGpPWpGaD
Crizotinib—SRC—BDNF signaling pathway—ALPL—Paget's disease of bone	0.000494	0.000812	CbGpPWpGaD
Crizotinib—YES1—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000493	0.000811	CbGpPWpGaD
Crizotinib—SRC—TGF-beta Signaling Pathway—PML—Paget's disease of bone	0.000487	0.000801	CbGpPWpGaD
Crizotinib—YES1—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000476	0.000782	CbGpPWpGaD
Crizotinib—IRAK1—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000468	0.000769	CbGpPWpGaD
Crizotinib—TXK—Immune System—PML—Paget's disease of bone	0.000458	0.000754	CbGpPWpGaD
Crizotinib—TYK2—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000454	0.000747	CbGpPWpGaD
Crizotinib—IRAK1—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000451	0.000742	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—VCP—Paget's disease of bone	0.000451	0.000742	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—VCP—Paget's disease of bone	0.000451	0.000742	CbGpPWpGaD
Crizotinib—CDK7—Cell Cycle—NUP205—Paget's disease of bone	0.000444	0.00073	CbGpPWpGaD
Crizotinib—TXK—Immune System—INPP5D—Paget's disease of bone	0.000442	0.000727	CbGpPWpGaD
Crizotinib—TYK2—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000438	0.00072	CbGpPWpGaD
Crizotinib—JAK3—Hemostasis—INPP5D—Paget's disease of bone	0.00043	0.000706	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—VCP—Paget's disease of bone	0.000428	0.000703	CbGpPWpGaD
Crizotinib—YES1—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000427	0.000701	CbGpPWpGaD
Crizotinib—LCK—HIV Infection—NUP205—Paget's disease of bone	0.00042	0.00069	CbGpPWpGaD
Crizotinib—LYN—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000416	0.000684	CbGpPWpGaD
Crizotinib—PRKD1—Metabolism—NUP205—Paget's disease of bone	0.000412	0.000678	CbGpPWpGaD
Crizotinib—IRAK1—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000405	0.000665	CbGpPWpGaD
Crizotinib—SRC—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.000399	0.000656	CbGpPWpGaD
Crizotinib—IRAK1—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000398	0.000654	CbGpPWpGaD
Crizotinib—TXK—Immune System—SQSTM1—Paget's disease of bone	0.000396	0.000652	CbGpPWpGaD
Crizotinib—IKBKE—Immune System—NUP205—Paget's disease of bone	0.000393	0.000646	CbGpPWpGaD
Crizotinib—SRC—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.000393	0.000646	CbGpPWpGaD
Crizotinib—TYK2—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000393	0.000646	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—VCP—Paget's disease of bone	0.000391	0.000643	CbGpPWpGaD
Crizotinib—JAK2—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000389	0.00064	CbGpPWpGaD
Crizotinib—TYK2—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000386	0.000635	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—SQSTM1—Paget's disease of bone	0.00037	0.000608	CbGpPWpGaD
Crizotinib—LYN—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000368	0.000605	CbGpPWpGaD
Crizotinib—FGR—Hemostasis—INPP5D—Paget's disease of bone	0.000367	0.000604	CbGpPWpGaD
Crizotinib—SRC—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000362	0.000596	CbGpPWpGaD
Crizotinib—STK4—Signaling Pathways—CALCA—Paget's disease of bone	0.000359	0.000591	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—NUP205—Paget's disease of bone	0.000358	0.000588	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—NUP205—Paget's disease of bone	0.000358	0.000588	CbGpPWpGaD
Crizotinib—LYN—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000355	0.000583	CbGpPWpGaD
Crizotinib—PRKD1—Metabolism—INPP5D—Paget's disease of bone	0.000352	0.000578	CbGpPWpGaD
Crizotinib—IKBKE—Immune System—PML—Paget's disease of bone	0.000347	0.000571	CbGpPWpGaD
Crizotinib—JAK2—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000344	0.000566	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—VCP—Paget's disease of bone	0.000342	0.000562	CbGpPWpGaD
Crizotinib—LCK—Cytokine Signaling in Immune system—NUP205—Paget's disease of bone	0.000341	0.000561	CbGpPWpGaD
Crizotinib—IKBKE—Immune System—INPP5D—Paget's disease of bone	0.000335	0.000551	CbGpPWpGaD
Crizotinib—JAK2—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000332	0.000546	CbGpPWpGaD
Crizotinib—RIPK2—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000331	0.000544	CbGpPWpGaD
Crizotinib—BLK—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000318	0.000524	CbGpPWpGaD
Crizotinib—LYN—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000318	0.000523	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—PML—Paget's disease of bone	0.000316	0.00052	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—PML—Paget's disease of bone	0.000316	0.00052	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000314	0.000517	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—VCP—Paget's disease of bone	0.000309	0.000508	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—CALCA—Paget's disease of bone	0.000305	0.000502	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—INPP5D—Paget's disease of bone	0.000305	0.000501	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—INPP5D—Paget's disease of bone	0.000305	0.000501	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—VCP—Paget's disease of bone	0.000303	0.000497	CbGpPWpGaD
Crizotinib—LCK—Cytokine Signaling in Immune system—PML—Paget's disease of bone	0.000301	0.000496	CbGpPWpGaD
Crizotinib—PTK2—Hemostasis—INPP5D—Paget's disease of bone	0.0003	0.000494	CbGpPWpGaD
Crizotinib—IKBKE—Immune System—SQSTM1—Paget's disease of bone	0.0003	0.000494	CbGpPWpGaD
Crizotinib—CDK7—Disease—VCP—Paget's disease of bone	0.000298	0.00049	CbGpPWpGaD
Crizotinib—JAK2—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000298	0.000489	CbGpPWpGaD
Crizotinib—YES1—Hemostasis—INPP5D—Paget's disease of bone	0.000296	0.000487	CbGpPWpGaD
Crizotinib—JAK2—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000293	0.000481	CbGpPWpGaD
Crizotinib—TBK1—Immune System—NUP205—Paget's disease of bone	0.000292	0.00048	CbGpPWpGaD
Crizotinib—LCK—Cytokine Signaling in Immune system—INPP5D—Paget's disease of bone	0.000291	0.000478	CbGpPWpGaD
Crizotinib—MAPK7—Signaling by GPCR—CALCA—Paget's disease of bone	0.000291	0.000478	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—NUP205—Paget's disease of bone	0.00028	0.000461	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—SQSTM1—Paget's disease of bone	0.000273	0.000449	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—SQSTM1—Paget's disease of bone	0.000273	0.000449	CbGpPWpGaD
Crizotinib—JAK3—Immune System—NUP205—Paget's disease of bone	0.000264	0.000434	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000264	0.000433	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000264	0.000433	CbGpPWpGaD
Crizotinib—LCK—Cytokine Signaling in Immune system—SQSTM1—Paget's disease of bone	0.000261	0.000429	CbGpPWpGaD
Crizotinib—TBK1—Immune System—PML—Paget's disease of bone	0.000258	0.000425	CbGpPWpGaD
Crizotinib—LCK—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000256	0.000421	CbGpPWpGaD
Crizotinib—YES1—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000256	0.000421	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—CALCA—Paget's disease of bone	0.000256	0.000421	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—CALCA—Paget's disease of bone	0.000256	0.000421	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—SQSTM1—Paget's disease of bone	0.00025	0.000411	CbGpPWpGaD
Crizotinib—TBK1—Immune System—INPP5D—Paget's disease of bone	0.000249	0.00041	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—PML—Paget's disease of bone	0.000248	0.000407	CbGpPWpGaD
Crizotinib—CDK7—Gene Expression—NUP205—Paget's disease of bone	0.000245	0.000404	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—CALCA—Paget's disease of bone	0.000243	0.000399	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—INPP5D—Paget's disease of bone	0.000239	0.000393	CbGpPWpGaD
Crizotinib—JAK3—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000236	0.000389	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—NUP205—Paget's disease of bone	0.000235	0.000387	CbGpPWpGaD
Crizotinib—JAK3—Immune System—PML—Paget's disease of bone	0.000234	0.000384	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—NUP205—Paget's disease of bone	0.000232	0.000382	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000228	0.000376	CbGpPWpGaD
Crizotinib—CDK7—Disease—NUP205—Paget's disease of bone	0.000228	0.000375	CbGpPWpGaD
Crizotinib—SRC—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000227	0.000373	CbGpPWpGaD
Crizotinib—BLK—Immune System—NUP205—Paget's disease of bone	0.000227	0.000372	CbGpPWpGaD
Crizotinib—FGR—Immune System—NUP205—Paget's disease of bone	0.000226	0.000371	CbGpPWpGaD
Crizotinib—JAK3—Immune System—INPP5D—Paget's disease of bone	0.000225	0.00037	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—VCP—Paget's disease of bone	0.000224	0.000368	CbGpPWpGaD
Crizotinib—TBK1—Immune System—SQSTM1—Paget's disease of bone	0.000223	0.000367	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—CALCA—Paget's disease of bone	0.000222	0.000365	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—INPP5D—Paget's disease of bone	0.000221	0.000363	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—INPP5D—Paget's disease of bone	0.00022	0.000362	CbGpPWpGaD
Crizotinib—JAK3—Signaling by GPCR—CALCA—Paget's disease of bone	0.000215	0.000353	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000214	0.000352	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—SQSTM1—Paget's disease of bone	0.000214	0.000352	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—PML—Paget's disease of bone	0.000208	0.000342	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—INPP5D—Paget's disease of bone	0.000207	0.00034	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—PML—Paget's disease of bone	0.000205	0.000337	CbGpPWpGaD
Crizotinib—TYK2—Disease—VCP—Paget's disease of bone	0.000203	0.000333	CbGpPWpGaD
Crizotinib—JAK3—Immune System—SQSTM1—Paget's disease of bone	0.000202	0.000332	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—INPP5D—Paget's disease of bone	0.000201	0.00033	CbGpPWpGaD
Crizotinib—BLK—Immune System—PML—Paget's disease of bone	0.0002	0.000329	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—SQSTM1—Paget's disease of bone	0.0002	0.000328	CbGpPWpGaD
Crizotinib—FGR—Immune System—PML—Paget's disease of bone	0.0002	0.000328	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—VCP—Paget's disease of bone	0.000199	0.000328	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—INPP5D—Paget's disease of bone	0.000198	0.000325	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—VCP—Paget's disease of bone	0.000196	0.000323	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—CALCA—Paget's disease of bone	0.000194	0.000319	CbGpPWpGaD
Crizotinib—BLK—Immune System—INPP5D—Paget's disease of bone	0.000193	0.000318	CbGpPWpGaD
Crizotinib—FGR—Immune System—INPP5D—Paget's disease of bone	0.000193	0.000317	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000191	0.000314	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—VCP—Paget's disease of bone	0.000188	0.000309	CbGpPWpGaD
Crizotinib—PTK2—Immune System—NUP205—Paget's disease of bone	0.000185	0.000304	CbGpPWpGaD
Crizotinib—YES1—Immune System—NUP205—Paget's disease of bone	0.000182	0.0003	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—VCP—Paget's disease of bone	0.000182	0.0003	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—INPP5D—Paget's disease of bone	0.000181	0.000298	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000181	0.000297	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—SQSTM1—Paget's disease of bone	0.00018	0.000296	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—SQSTM1—Paget's disease of bone	0.000177	0.000292	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000177	0.000291	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—CALCA—Paget's disease of bone	0.000175	0.000288	CbGpPWpGaD
Crizotinib—BLK—Immune System—SQSTM1—Paget's disease of bone	0.000173	0.000285	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—NUP205—Paget's disease of bone	0.000173	0.000284	CbGpPWpGaD
Crizotinib—FGR—Immune System—SQSTM1—Paget's disease of bone	0.000173	0.000284	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—CALCA—Paget's disease of bone	0.000172	0.000282	CbGpPWpGaD
Crizotinib—CDK7—Disease—CALCA—Paget's disease of bone	0.000169	0.000278	CbGpPWpGaD
Crizotinib—TYK2—Immune System—NUP205—Paget's disease of bone	0.000168	0.000276	CbGpPWpGaD
Crizotinib—PTK2—Immune System—PML—Paget's disease of bone	0.000163	0.000269	CbGpPWpGaD
Crizotinib—YES1—Immune System—PML—Paget's disease of bone	0.000161	0.000265	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—INPP5D—Paget's disease of bone	0.00016	0.000264	CbGpPWpGaD
Crizotinib—PTK2—Immune System—INPP5D—Paget's disease of bone	0.000158	0.000259	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000157	0.000257	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—VCP—Paget's disease of bone	0.000156	0.000257	CbGpPWpGaD
Crizotinib—YES1—Immune System—INPP5D—Paget's disease of bone	0.000155	0.000256	CbGpPWpGaD
Crizotinib—TYK2—Disease—NUP205—Paget's disease of bone	0.000155	0.000255	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—VCP—Paget's disease of bone	0.000154	0.000253	CbGpPWpGaD
Crizotinib—JAK2—Disease—VCP—Paget's disease of bone	0.000154	0.000253	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—PML—Paget's disease of bone	0.000153	0.000251	CbGpPWpGaD
Crizotinib—TYK2—Immune System—PML—Paget's disease of bone	0.000148	0.000244	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—INPP5D—Paget's disease of bone	0.000147	0.000242	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—VCP—Paget's disease of bone	0.000146	0.00024	CbGpPWpGaD
Crizotinib—TYK2—Immune System—INPP5D—Paget's disease of bone	0.000143	0.000235	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—VCP—Paget's disease of bone	0.000142	0.000233	CbGpPWpGaD
Crizotinib—PTK2—Immune System—SQSTM1—Paget's disease of bone	0.000141	0.000232	CbGpPWpGaD
Crizotinib—YES1—Immune System—SQSTM1—Paget's disease of bone	0.000139	0.000229	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000139	0.000228	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—CALCA—Paget's disease of bone	0.000136	0.000224	CbGpPWpGaD
Crizotinib—LYN—Immune System—NUP205—Paget's disease of bone	0.000136	0.000223	CbGpPWpGaD
Crizotinib—ABL1—Immune System—NUP205—Paget's disease of bone	0.000135	0.000222	CbGpPWpGaD
Crizotinib—LCK—Disease—VCP—Paget's disease of bone	0.000135	0.000221	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—SQSTM1—Paget's disease of bone	0.000132	0.000217	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000131	0.000215	CbGpPWpGaD
Crizotinib—TYK2—Immune System—SQSTM1—Paget's disease of bone	0.000128	0.000211	CbGpPWpGaD
Crizotinib—JAK2—Immune System—NUP205—Paget's disease of bone	0.000127	0.000209	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—CALCA—Paget's disease of bone	0.000127	0.000208	CbGpPWpGaD
Crizotinib—LYN—Immune System—PML—Paget's disease of bone	0.00012	0.000197	CbGpPWpGaD
Crizotinib—ABL1—Immune System—PML—Paget's disease of bone	0.00012	0.000197	CbGpPWpGaD
Crizotinib—SRC—Disease—VCP—Paget's disease of bone	0.000119	0.000196	CbGpPWpGaD
Crizotinib—JAK2—Disease—NUP205—Paget's disease of bone	0.000117	0.000193	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000116	0.000191	CbGpPWpGaD
Crizotinib—LYN—Immune System—INPP5D—Paget's disease of bone	0.000116	0.000191	CbGpPWpGaD
Crizotinib—ABL1—Immune System—INPP5D—Paget's disease of bone	0.000115	0.00019	CbGpPWpGaD
Crizotinib—TYK2—Disease—CALCA—Paget's disease of bone	0.000115	0.000189	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—VCP—Paget's disease of bone	0.000115	0.000189	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000115	0.000189	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000114	0.000187	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—CALCA—Paget's disease of bone	0.000113	0.000186	CbGpPWpGaD
Crizotinib—JAK2—Immune System—PML—Paget's disease of bone	0.000112	0.000185	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—CALCA—Paget's disease of bone	0.000111	0.000183	CbGpPWpGaD
Crizotinib—LCK—Immune System—NUP205—Paget's disease of bone	0.000111	0.000183	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.00011	0.00018	CbGpPWpGaD
Crizotinib—JAK2—Immune System—INPP5D—Paget's disease of bone	0.000108	0.000178	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—VCP—Paget's disease of bone	0.000108	0.000177	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—CALCA—Paget's disease of bone	0.000107	0.000175	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—SQSTM1—Paget's disease of bone	0.000106	0.000175	CbGpPWpGaD
Crizotinib—LYN—Immune System—SQSTM1—Paget's disease of bone	0.000104	0.000171	CbGpPWpGaD
Crizotinib—ABL1—Immune System—SQSTM1—Paget's disease of bone	0.000103	0.00017	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—CALCA—Paget's disease of bone	0.000103	0.00017	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—CALCA—Paget's disease of bone	0.000103	0.00017	CbGpPWpGaD
Crizotinib—LCK—Disease—NUP205—Paget's disease of bone	0.000103	0.000169	CbGpPWpGaD
Crizotinib—SRC—Immune System—NUP205—Paget's disease of bone	9.86e-05	0.000162	CbGpPWpGaD
Crizotinib—LCK—Immune System—PML—Paget's disease of bone	9.84e-05	0.000162	CbGpPWpGaD
Crizotinib—JAK2—Immune System—SQSTM1—Paget's disease of bone	9.72e-05	0.00016	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	9.63e-05	0.000158	CbGpPWpGaD
Crizotinib—LCK—Immune System—INPP5D—Paget's disease of bone	9.5e-05	0.000156	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—VCP—Paget's disease of bone	9.42e-05	0.000155	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—SQSTM1—Paget's disease of bone	9.13e-05	0.00015	CbGpPWpGaD
Crizotinib—SRC—Disease—NUP205—Paget's disease of bone	9.1e-05	0.00015	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—SQSTM1—Paget's disease of bone	9.01e-05	0.000148	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—CALCA—Paget's disease of bone	8.87e-05	0.000146	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—CALCA—Paget's disease of bone	8.75e-05	0.000144	CbGpPWpGaD
Crizotinib—JAK2—Disease—CALCA—Paget's disease of bone	8.72e-05	0.000143	CbGpPWpGaD
Crizotinib—SRC—Immune System—PML—Paget's disease of bone	8.71e-05	0.000143	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—SQSTM1—Paget's disease of bone	8.54e-05	0.00014	CbGpPWpGaD
Crizotinib—LCK—Immune System—SQSTM1—Paget's disease of bone	8.51e-05	0.00014	CbGpPWpGaD
Crizotinib—SRC—Immune System—INPP5D—Paget's disease of bone	8.41e-05	0.000138	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—VCP—Paget's disease of bone	8.34e-05	0.000137	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—CALCA—Paget's disease of bone	8.3e-05	0.000136	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—SQSTM1—Paget's disease of bone	8.29e-05	0.000136	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—CALCA—Paget's disease of bone	8.05e-05	0.000132	CbGpPWpGaD
Crizotinib—LCK—Disease—CALCA—Paget's disease of bone	7.63e-05	0.000126	CbGpPWpGaD
Crizotinib—SRC—Immune System—SQSTM1—Paget's disease of bone	7.54e-05	0.000124	CbGpPWpGaD
Crizotinib—SRC—Disease—CALCA—Paget's disease of bone	6.76e-05	0.000111	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—SQSTM1—Paget's disease of bone	6.72e-05	0.00011	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CALCA—Paget's disease of bone	6.52e-05	0.000107	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—SQSTM1—Paget's disease of bone	6.28e-05	0.000103	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CALCA—Paget's disease of bone	6.1e-05	0.0001	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—NUP205—Paget's disease of bone	5.98e-05	9.83e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—SQSTM1—Paget's disease of bone	5.5e-05	9.05e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CALCA—Paget's disease of bone	5.35e-05	8.79e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—INPP5D—Paget's disease of bone	5.1e-05	8.38e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—SQSTM1—Paget's disease of bone	4.87e-05	8.01e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CALCA—Paget's disease of bone	4.73e-05	7.78e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—NUP205—Paget's disease of bone	4.51e-05	7.42e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—INPP5D—Paget's disease of bone	3.85e-05	6.32e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—NUP205—Paget's disease of bone	2.78e-05	4.57e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—INPP5D—Paget's disease of bone	2.37e-05	3.9e-05	CbGpPWpGaD
